Page 9 - Hartley Atkinson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hartley atkinson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hartley Atkinson Today - Breaking & Trending Today

Children's medicines 'quite challenging' to develop: AFT Pharmaceutical CEO

Children's medicines 'quite challenging' to develop: AFT Pharmaceutical CEO
stuff.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuff.co.nz Daily Mail and Mail on Sunday newspapers.

United States , New Zealand , Hartley Atkinson , Drug Administration , Maxigesic Oral Liquid , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜீலாந்து , ஹார்ட்லி அட்கின்சன் ,

Covid-free Australia would help AFT Pharmaceuticals' growth


Sales grew from $105 million the previous year to $113m, compared with April guidance of $111m. Underlying operating profit of $10.7m was near the upper end of a downgraded forecast of between $9m and $11m. Excluding a one-off gain, operating profit in the previous year was $11.4m.
The company expected operating profit this year between $18m and $23m.
However, investors will have to wait for a dividend as AFT first wanted to reduce its net debt to between $25m and $30m. Net debt fell to $35.2m from $37.1m during the year.
AFT signed a number of deals remotely during the year, which was challenge, Atkinson​ said. ....

United States , New Zealand , Hartley Atkinson , United Hikma Pharmaceuticals , United Kingdom Based Hikma Pharmaceuticals , North America , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜீலாந்து , ஹார்ட்லி அட்கின்சன் , வடக்கு அமெரிக்கா ,

AFT Pharmaceuticals reports $7.8m net profit


Local drugmaker AFT Pharmaceuticals has posted a lower full-year profit as the pandemic and disruptions to its supply chain affected sales.
AFT Pharmaceuticals underlying profit for the year was $10.8m, in line with guidance given last month.
Photo: 123RF
The company reported a net profit of $7.8 million for the year ended March compared with a profit of $12.7m the year before, although that was inflated by a $9.8m one-off gain.
AFT managing director Hartley Atkinson said the year had been challenging but the company had made progress in revenue and recognition of its key product, the Maxigesic painkiller range.
We have delivered these improved financial results in the face of multiple supply disruptions, delays to product launches, to regulatory approvals and to manufacturing audits around the world. ....

New Zealand , United States , Hartley Atkinson , North America , புதியது ஜீலாந்து , ஒன்றுபட்டது மாநிலங்களில் , ஹார்ட்லி அட்கின்சன் , வடக்கு அமெரிக்கா ,

Drug company's shares surge after deal signed in world's largest market


AFT Pharmaceuticals chief executive Hartley Atkinson says the US pharmaceutical market is key for the company,
Shares in AFT Pharmaceuticals soared as much as 18 per cent after it signed its first distribution deal in the United States, the world s largest drug market.
The Auckland-based company said on Wednesday it had signed an exclusive licensing and distribution deal with Hikma Pharmaceuticals for the commercialisation of its intravenous, opioid-free Maxigesic IV post-operative pain relief medicine in the US. Based in the United Kingdom, Hikma is the third-largest supplier of generic injectable medications by volume in the US.
The deal gives AFT a foothold into a post-operative pain management medication market worth an estimated US$745 million (NZ$1 billion) in 2019, and expected to grow to US$1.7b (NZ$2.4b) by 2028. The company’s product offers an alternative to opioids in the US, where addiction to the drugs has become an epidemic. ....

New Zealand , United States , United Kingdom , Hartley Atkinson , Drug Administration , Hikma Pharmaceuticals , புதியது ஜீலாந்து , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஹார்ட்லி அட்கின்சன் , ஹிக்மா மருந்துகள் ,